Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

WELLBUTRIN SR

BUPROPION HYDROCHLORIDE

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview WELLBUTRIN SR is listed in Drugs@FDA under application 020358 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPROPION HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 50MG Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2025-11-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview WELLBUTRIN SR is listed in Drugs@FDA under application 020358 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BUPROPION HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 50MG Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2025-11-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) | Drug Monograph | MedicHelpline